Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Roche View On Biogenerics: “They Will Come,” But Process Won’t Be Simple

Aug 04 2003

• By The Pink Sheet

Related Content

Roche Specialty Market Focus Provides Refuge In “Unstable Environment”

Jul 28 2003

J&J Eprex Sales Stabilize As Aplasia Cases Decline; Patient Registry Planned

Jul 21 2003

Roche/Corange divesting Retavase to Centocor; biotech firm to co-promote ReoPro with Lilly.

Feb 16 1998

J&J Eprex “Best Handling Practices” Program Aims To Reduce PRCA Cases

Dec 09 2002

Roche Will Challenge Amgen In U.S. EPO Market; Oncology Business Growing

Aug 04 2003

Recombinant Drugs Too Complex For 505(b)(2), Should Go To CBER – Amgen

Jan 14 2002

J&J Eprex Stability Improvements Planned In Response To Aplasia Incidence

Sep 16 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window